Dale VanderPutten, CEO of Omnia, said: “Vladimir Slepushkin and his team’s breadth of experience in biologics from R&D through clinical development in a wide variety disease targets and platforms make Biotech Experts services truly unique and valuable.
“Their pioneering work in adenovirus and lentivirus vectors, and cell line development was crucial to moving several novel products from bench to clinic.”
Omnia is a contract manufacturer focused on process development and clinical trials material manufacturing of innovative biopharmaceuticals. Omnia offers services in the areas of process development, GMP manufacture, and fill-finish for preclinical and clinical programs for therapeutics that do not have effective or known manufacturing protocols.
Biotech Experts accelerates development of new biological therapies for life-threatening diseases by providing consulting services to the biotech community. Biotech Experts represents decades of experience in the biotech industry.